Rochester, NY, United States of America

James Macdonald

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Astra Aktiebolag, Astrazeneca Ab. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Macdonald. Retrieved from https://idiyas.com/inventor/james-macdonald-l86w6d0g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of James Macdonald

Introduction

James Macdonald is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds that have practical applications in medicine. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

One of his latest patents is titled "Amidine derivatives as inhibitors of nitric oxide synthase." This innovative work focuses on compounds that can potentially play a crucial role in therapeutic applications, particularly in the treatment of various medical conditions.

Career Highlights

Throughout his career, James Macdonald has worked with prominent companies such as AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

James has collaborated with esteemed colleagues, including James Russell Matz and William C. Shakespeare. These partnerships have further enriched his research and development efforts.

Conclusion

James Macdonald's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…